Assignee
GENCIA CORP
US·3 granted patents·9 pending applications·23 citations·filing 2004–2017
Top patents by PatentIndex Score
12 records- 0184US8039587B2Methods and compositions for delivering polynucleotidesGENCIA CORP·Filed 2004·Granted Oct 18, 2011·22 cites·6 claims
- 0267US9434753B2Modified creatine compoundsGENCIA CORP·Filed 2012·Granted Sep 6, 2016·1 cites·18 claims
- 0367US2009208478A1Transducible polypeptides for modifying metabolismGENCIA CORP·Filed 2009·Application pending·0 cites
- 0459US9707244B2Compositions and methods for treating conditions that affect epidermisGENCIA CORP·Filed 2014·Granted Jul 18, 2017·0 cites·17 claims
- 0559US2010179106A1Mitochondrial compositions and uses thereofGENCIA CORP·Filed 2008·Application pending·0 cites
- 0658US2014113853A1Transducible Polypeptides for Modifying MetabolismGENCIA CORP·Filed 2013·Application pending·0 cites
- 0756US2009123468A1Transducible polypeptides for modifying metabolismGENCIA CORP·Filed 2008·Application pending·0 cites
- 0853US2014045798A1Mitochondrial compositions and uses thereofGENCIA CORP·Filed 2013·Application pending·0 cites
- 0950US2007196334A1Modified vectors for organelle transfectionGENCIA CORP·Filed 2004·Application pending·0 cites
- 1049US2018000846A1Compositions and Methods for Treating Conditions That Affect EpidermisGENCIA CORP·Filed 2017·Application pending·0 cites
- 1148US2015283233A1Compositions and Methods for Enhancing Immune ResponsesGENCIA CORP·Filed 2013·Application pending·0 cites
- 1248US2016038565A1Methods of Mitigating Side Effects of Radiation Exposure and ChemotherapyGENCIA CORP·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →